Business Context and Reporting Period
Company: Marti Technologies, Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three and six months ended June 30, 2026 (compared to 2025)
Filing Date: August 19, 2026
Principal Executive Office: Istanbul, Türkiye
This filing serves as a cover document incorporating by reference the Management's Discussion and Analysis (Exhibit 99.1) and Unaudited Interim Condensed Consolidated Financial Statements (Exhibit 99.2). The document itself does not contain the detailed financial data.
Key Financial Metrics
The filing text provided is a cover sheet and does not contain specific numerical values for the following metrics. These figures are located in the attached Exhibits 99.1 and 99.2, which are not included in the input text:
- Revenue: Not provided in text.
- Profit/Loss: Not provided in text.
- Cash Flow: Not provided in text.
- Margins: Not provided in text.
- Debt and Liquidity: Not provided in text.
Material Changes
The filing text does not provide specific details regarding material changes in financial condition or results of operations compared to the prior comparable period. Such analysis is contained within the incorporated Exhibit 99.1.
Guidance, Outlook, and Risks
Management Commentary: The text confirms the existence of a Management's Discussion and Analysis but does not include the content of that discussion.
Guidance and Outlook: No forward-looking guidance or outlook is present in the cover document.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: No unusual items are described in the cover document.
Investor Verification Checklist
- Verify the specific revenue and net income figures in Exhibit 99.2 (Unaudited Interim Condensed Consolidated Financial Statements).
- Review Exhibit 99.1 for management's explanation of year-over-year performance changes.
- Confirm the company's liquidity position and debt covenants in the financial statements.
- Check for any updates to risk factors or legal contingencies in the full MD&A.
- Validate the incorporation by reference into the specified Form F-3 and Form S-8 registration statements.